Figure 1.
Figure 1. Survival outcomes after RIC-HSCT in myeloma. Median OS has not been reached, two-year OS was 69.2%.

Survival outcomes after RIC-HSCT in myeloma. Median OS has not been reached, two-year OS was 69.2%.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal